Dapivirine Vaginal Ring Safe, Effective at Preventing HIV During Pregnancy – Physician’s Weekly
THURSDAY, March 14, 2024 (HealthDay News) — Adverse pregnancy outcomes related to use of the dapivirine vaginal ring (DVR) or daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) during the second trimester are uncommon, according to a study presented at the annual Conference on Retroviruses and Opportunistic Infections, held from March 3 to 6 in Denver. Felix